The following information is provided to satisfy virtual marking requirements of various jurisdictions including Section 287(a) of Title 35 of the United States Code and to provide notice of patent rights of Astrea UK Services Limited.
Astrea Bioseparations products are covered by or for use under one or more of the following U.S. patents and other country patents. Other patents pending.
|AstreAdept®, LentiHERO®, ExoHERO® and pDNAHERO®
|US 9,604,168; US RE49,773
Last updates: 13 February 2024